1933 Industries Inc., a cannabis cultivation and production company based in Nevada, has announced a robust financial performance for the first quarter of fiscal 2026. The company reported a net income of CAD 139,219, marking its third consecutive quarter of profitability. This achievement reflects a commendable turnaround in the company's financial health compared to the previous year, during which it reported a net loss.
For the three months ending October 31, 2025, 1933 Industries generated revenues of approximately CAD 4.0 million, alongside a gross profit of CAD 1.0 million, which equates to a gross margin of 25%. This is a slight dip from the prior year's gross margin, yet it showcases significant operational resilience.
The company's expenses notably decreased to CAD 0.8 million from CAD 1.9 million in the same period last year, primarily due to effective cost-saving measures initiated by the management. This drop in expenditures highlights the company’s focused efforts on operational efficiency.
As the owner of the Alternative Medicine Association (AMA), 1933 Industries continues to position itself as a prominent player in the Nevada cannabis market. The AMA brand is recognized as one of the top five selling cannabis brands in the state, particularly known for its high-quality flower, pre-rolls, and specialty concentrates.
CEO Brian Farrell expressed optimism regarding the company's financial turnaround, emphasizing a commitment to maintaining quality while pursuing sustainable growth. He noted the positive implications of regulatory changes, particularly a recent directive from U.S. President Donald Trump that may lead to a reclassification of cannabis under federal law.
This reclassification could enhance operational conditions for cannabis businesses in the U.S., potentially reducing tax burdens and expanding access to banking services. 1933 Industries intends to take advantage of these developments to further its growth in the evolving cannabis sector.
In Q1 2026, 1933 Industries reported revenue of approximately CAD 4.0 million and achieved a gross profit of CAD 1.0 million with a gross margin of 25%. This reflects a significant operational turnaround as the company reported net income of CAD 139,219, marking its third consecutive profitable quarter.
The company successfully reduced its expenses to CAD 0.8 million from CAD 1.9 million through effective cost-saving initiatives. This demonstrates the management’s focus on operational efficiency and cost control, which has positively impacted profitability.
The recent executive order aimed at reclassifying cannabis from a Schedule I to a Schedule III substance could enhance the operating environment for cannabis businesses, potentially reducing tax burdens and improving access to banking services. Such developments are favourable for the industry's growth and could bode well for 1933 Industries.
1933 Industries, through its Alternative Medicine Association brand, has established itself as a top 5 seller of cannabis products in Nevada. This strong market presence may provide a robust platform for future growth as demand for cannabis products continues to evolve.
Compared to the same period last year, 1933 Industries has made a remarkable recovery, moving from a net loss of CAD 577,829 to a net income of CAD 139,219 in Q1 2026, indicating a solid revenue growth trajectory despite a slight decline in gross profit.
Management has indicated a steadfast commitment to improving operational efficiencies while exploring strategic opportunities that align with regulatory developments in the cannabis sector, positioning the company for long-term sustainable growth.
The AMA brand’s products, which include cannabis flower, pre-rolls, and boutique concentrates, consistently rank as top sellers in Nevada, signalling consumer preference and strong market acceptance.
With potential regulatory reforms and a focus on expanding its product lines, particularly in the hemp-derived CBD market, 1933 Industries appears well-positioned to capitalise on emerging trends and opportunities within the growing cannabis industry.